Introduction {#s1}
============

In eukaryotes, target of rapamycin (TOR) is a conserved master regulator of metabolic signaling that integrates nutrient, energy, hormone, growth and stress inputs with cell growth and metabolism ([@bib59]; [@bib34]; [@bib66]). In yeast and mammalian cells, TOR associates with different interactors to form two functional complexes, TOR complex 1 (TORC1) and TOR complex 2 (TORC2) ([@bib59]). The Arabidopsis genome encodes functional homologs of TOR (AtTOR) and two TOR-interactors: LST8 (AtLST8-1 and AtLST8-2) and a specific component of TORC1, RAPTOR (AtRAPTOR1A and AtRAPTOR1B) ([@bib66]). The Arabidopsis homologs of TORC2-specific components have not been identified yet.

The yeast and mammalian TORC1 and TORC2 receive specific inputs and regulate distinct downstream processes. For example, sensors of leucine (Leu) and other amino acids provide input signals to TORC1 ([@bib59]; [@bib34]), while mammalian TORC2 is primarily regulated by the insulin-PI3K signaling and is inhibited by mTORC1 effectors ([@bib59]; [@bib77]). The current model of plant TOR signaling is built upon the three TORC1 components identified to date and envisions that TORC1 has essential functions, including promoting synthesis of proteins, nucleotides and lipids, and inhibiting autophagy for cell growth and proliferation ([@bib66]).

In plants, TOR has assumed critical and specific roles, including involvement in phytohormone signaling pathways (i.e., auxin \[[@bib36]; [@bib11]; [@bib61]\], cytokinin \[[@bib49]\], brassinosteroid \[[@bib84]; [@bib80]\] and abscisic acid \[[@bib73]\]), as well as metabolic signaling (e.g., glucosinolates \[[@bib41]\], sulfur sensing \[[@bib20]\]). Despite these advances, it is not well elucidated which inputs activate plant TOR signaling. In yeast and mammalian models, nutrient sensing of amino acids, especially the branched-chain amino acids (BCAAs) Leu, isoleucine (Ile) and valine (Val), is the primary input underlying activation of TOR signaling ([@bib59]; [@bib34]). Studies in plants revealed a glucose-TOR signaling pathway that integrates light and sugar availability to control meristem activation in root and shoot ([@bib36]; [@bib11]; [@bib49]; [@bib79]), connecting TOR signaling to the generation and availability of photosynthates. A recent work identified isopropylmalate synthase 1 (IPMS1), a critical enzyme for Leu biosynthesis, as a suppressor of *lrx1*, a mutant that is defective in root hair development ([@bib60]). Additionally, this research found that mutation of IPMS1 affects root development by reducing its sensitivity to chemical inhibition of TOR ([@bib60]), suggesting alteration of Leu biosynthesis modifies the TOR network. Therefore, the level of conservation of TOR signaling input across kingdoms and in plant cells specifically is still a significant question.

Investigating the relationship between BCAAs and plant TOR signaling has been generally hindered by the innate capacity of plant cells to produce BCAAs ([@bib78]). In the chloroplast, the allosterically regulated enzymes threonine deaminase (TD), acetohydroxyacid synthase (AHAS) and IPMS are subjected to feedback inhibition, and contribute to BCAA homeostasis ([@bib78]). Mammalian cells are unable to synthesize BCAAs; consequently, starvation and repletion of BCAAs in the culture serum can be effective in stimulating TOR signaling ([@bib58]; [@bib31]). In contrast, for plant cells, exogenous feeding of a limited concentration of amino acids to the growth medium may not perturb BCAA homeostasis and trigger detectable activation of TOR signaling ([@bib79]). Moreover, supplementation of a single or a combination of multiple amino acids may confer intertwined feedback inhibition to the biosynthetic pathway, and lead to unpredictable disruption of amino acid homeostasis ([@bib27]; [@bib40]). Additionally, because TOR is the main negative regulator of autophagy and promotes protein synthesis, either chemical inhibition of BCAA biosynthesis and TOR activity or mutation of TOR signaling components does not specifically affect BCAAs but leads to substantial increases in almost all types of amino acids in plant cells ([@bib51]; [@bib85]; [@bib46]; [@bib45]; [@bib9]). In light of these considerations, it is therefore not surprising that little is known about the functional and physiological consequences of an up-regulation of TOR signaling in plants, especially at a subcellular level. In yeast and mammalian cells, induced activation of TOR governs numerous cellular processes, most evidently the inhibition of autophagy by TORC1 and the reorganization of actin cytoskeleton by TORC2 ([@bib59]). Although the mechanistic basis is not fully understood, it has been proposed that mTORC2 regulates reorganization of actin cytoskeleton through the AGC family protein kinases and Rho signaling ([@bib77]). Plants express AGC family-like homologs with specialized functions ([@bib28]) and Rho of Plants (ROP) members that signal to the cytoskeleton system ([@bib28]; [@bib23]). Moreover, recent studies reported an interaction between ROP2 and TOR in the context of TOR-auxin crosstalk ([@bib36]; [@bib61]). Nonetheless, direct functional connections between TOR signaling, cytoskeleton in plant growth and development are yet to be established ([@bib51]; [@bib45]; [@bib19]; [@bib57]; [@bib56]; [@bib1]; [@bib18]; [@bib81]).

The vacuole and the endoplasmic reticulum (ER) are the two organelles of largest membrane extension in plant cells ([@bib83]; [@bib69]). The central vacuole fulfills essential cellular functions such as providing turgor pressure, protein turnover and metabolite storage ([@bib83]). The ER is the gateway to the secretory pathway and a membrane network that weaves through nearly all the other types of organelles ([@bib69]; [@bib76]). Despite of the essential roles of the vacuole and the ER ([@bib83]; [@bib69]), mechanisms underpinning their morphogenesis are still largely undefined although homotypic membrane fusion is known to be required ([@bib83]; [@bib14]; [@bib68]). It is also yet unclear whether and how the dynamics of plant ER and vacuoles are controlled in response to different developmental and environmental clues. The dynamics of endomembrane system in plant cells are mechanistically different from mammalian cells. In the latter, the ER morphology, organization and dynamics are mainly driven by microtubules and microtubule-related motor proteins ([@bib75]). In net contrast, the plant ER is primarily anchored to and mobilized by the actomyosin system ([@bib83]; [@bib70]; [@bib71]). Plant vacuoles are also in close proximity to the actin cytoskeleton ([@bib83]). Furthermore, interactions between plant ER and vacuolar membranes with bundled actin filaments form ER strands and *trans*-vacuolar strands (TVSs) ([@bib71]). The regulatory mechanisms of these membrane structures are also unknown.

In this work, we report on the characterization of *eva1* (*ER, vacuole and actin 1*), a mutant with defects in vacuole morphogenesis and organization of actin filaments and endomembranes, which are associated mainly with actin in plant cells ([@bib71]). The *eva1* mutation is a loss-of-function allele of *IPMS1*, which encodes the first committed enzyme of Leu biosynthesis, resulting in elevated free Val levels. Through phenotypic and functional analyses of *eva1* and a series of other mutants of BCAA biosynthesis and TOR signaling, we demonstrate that the subcellular phenotypes of *eva1* specifically hinge upon up-regulation of TOR signaling, which in turn affects organization of actin and endomembranes, and plant development. Therefore, by focusing on mutants with constitutive TOR signaling mis-regulation due to altered endogenous BCAA levels, we demonstrated that plant TOR signaling is linked to BCAAs and is critical for the homeostasis of actin, endomembranes and growth. The broader implications of these findings are that, despite the acquisition of specialized functions of TOR signaling in plants, the activating inputs of TOR signaling and the subcellular consequences of TOR signaling mis-regulation are conserved across eukaryotes.

Results {#s2}
=======

Identification of a mutant with defects in vacuole morphogenesis {#s2-1}
----------------------------------------------------------------

We pursued a confocal microscopy-based screen on an EMS-mutagenized population to identify mutants with defects in the subcellular distribution of a GFP-tagged tonoplast intrinsic protein (TIP), GFP-δTIP ([@bib4]; [@bib15]). We focused on *eva1*, a mutant characterized by severe defects in vacuole morphology early in development. During the first 10 days after germination, in wild-type (WT) cotyledon epidermal cells, small vacuoles undergo membrane fusion to form a single large central vacuole ([@bib83]) ([Figure 1a](#fig1){ref-type="fig"}). In contrast, 10 day old *eva1* cotyledon epidermal cells displayed numerous additional vacuolar structures that vary in shape and size ([Figure 1b](#fig1){ref-type="fig"}). To further characterize *eva1* vacuolar phenotypes, we focused on two prominent vacuolar structures that are rarely observed in wild type: TVSs and presumably unfused vacuoles. As we introduced, TVSs are strands formed upon association between vacuolar membrane and bundled actin filaments ([@bib71]), which were greatly enhanced in number, length and thickness in *eva1* ([Figure 1---figure supplement 1a--d](#fig1s1){ref-type="fig"}). Besides, we defined presumably unfused vacuoles as spherical structures that are isolated from the large central vacuole and have diameter \>5 μm. Both two vacuolar phenotypes were attenuated in 20 day old *eva1* cotyledons, which closely resembled WT ([Figure 1c,d](#fig1){ref-type="fig"}). The *eva1* vacuole phenotypes were verified in 10 day old *eva1* cotyledons expressing γTIP-YFP ([@bib47]), which labels the large central vacuole and other vacuolar structures not marked by GFP-δTIP ([@bib29]) ([Figure 1---figure supplement 1e--h](#fig1s1){ref-type="fig"}). These results support that the tonoplast organization and vacuolar morphology are compromised in *eva1* in early stages of growth independently from the tonoplast marker used for the analyses.

![Identification of a mutant with defects in vacuole morphogenesis.\
(**a -- d**) Confocal images of cotyledon epidermal cells expressing tonoplast marker GFP-δTIP in 10 day old (**a and b**) and 20 day old (**c and d**) wild type and *eva1*. The top panels present single images of the middle focal plane of the epidermal cells. The bottom panels present Z-stack maximal projections, which is a stack of about 20 single images with 20 μm intervals that fully span the top-to-bottom Z-axis of the epidermal cells. Arrows point to TVSs and arrowheads indicate presumably small vacuoles, which are prominent in *eva1*. Scale bar in (**a** and **b**), 20 μm. Scale bar in (**c** and **d**), 50 μm. (**e**) Genomic structure of *IPMS1* (AT1G18500). Gray boxes: UTRs; black boxes: exons; lines: introns. (**f**) Amino acid sequence alignment of IPMS1 homologs using T-COFFEE in Jalview. Amino acids are grouped by color with ClustalX based on their similarity of physicochemical properties. At, *Arabidopsis thaliana*; Sl, *Solanum lycopersicum*; Cr, *Chlamydomonas reinhardtii*; Mt, *Mycobacterium tuberculosis*. The amino acid substitution of *eva1* is denoted by a red box. (**g** and **h**), Photographs of 10-day old (g) and 20-day old (h) plants. Scale bar in g, 0.5 cm. Scale bar in h, 1 cm.](elife-50747-fig1){#fig1}

We next aimed to identify the causative mutation in *eva1*. Bulked segregant analysis and whole-genome resequencing narrowed down the *eva1* mutation to a G-to-A transition in *IPMS1* (*AT1G18500*) causing an aspartate (Asp)-to-asparagine (Asn) residue substitution ([Figure 1e,f](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2a](#fig1s2){ref-type="fig"}). IPMS1 catalyzes condensation of 2-oxoisovalerate and acetyl-CoA into 2-isopropylmalate, the committed step for Leu biosynthesis ([@bib16]; [@bib24]) ([Figure 2a](#fig2){ref-type="fig"}). Homology modeling of IPMS1 predicted that the mutated Asp228 is located in the acetyl-CoA binding surface near the pocket for 2-oxoisovalerate substrate ([Figure 1---figure supplement 2b,c](#fig1s2){ref-type="fig"}). In addition to *eva1*, we used three other *IPMS1* alleles that had been characterized: two recessive loss-of-function mutants, *ipms1-4* and *ipms1-5*, and a gain-of-function *ipms1-1D*, with a point mutation that impairs allosteric regulation ([@bib78]; [@bib16]) ([Figure 1e](#fig1){ref-type="fig"}). 10 day old *eva1*, *ipms1-4* and *ipms1-5* seedlings exhibited similar delay in emergence of true leaves ([Figure 1g](#fig1){ref-type="fig"}). These growth and developmental phenotypes, as well as the subcellular phenotypes, were attenuated by 20 days of growth ([Figure 1h](#fig1){ref-type="fig"}). The presence of the *eva1* phenotypes in the *eva1* × *ipms1-5* F1 progeny confirmed allelism of *eva1* to *IPMS1* ([Figure 1---figure supplement 2d--f](#fig1s2){ref-type="fig"}). Together, these results support that the *eva1* vacuole and plant growth phenotypes are correlated to a loss of functional IPMS1, which has a consistent subcellular impact on early stages of growth.

![Amino acid profiling of *IPMS1* loss-of-function mutants.\
(**a**) Schematic of the BCAA biosynthetic pathway in the chloroplast. Red lines show known feedback inhibitions of enzymes by end products. (**b** and **c**) Fold changes of each free amino acid in *eva1*, *ipms1-4* and *ipms1-5* compared to wild type. Values are mean ± SEM. For 10 day-old sampling, n = 7 for WT, n = 5 for *eva1*, n = 8 for *ipms1-4*, n = 7 for *ipms1-5*. For 20 day-old sampling, n = 6 for each genotype. The asterisks indicate significant differences compared to the wild type (\*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, unpaired *t* test).\
Figure 2---source data 1.The BCAA biosynthesis pathway is up-regulated in young seedlings of *eva1* and *IPMS1* loss-of-function mutants.Amino acids were extracted from aerial tissues of 10 days old seedlings and rosette leaves of 20 days old plants. Each value represents the mean ± SEM. The asterisks indicate significant difference compared to the GFP-δTIP as wild type (WT) (\*p≤0.05, \*\*p≤0.01, \*\*\*p≤0.001, unpaired t test). aFW, fresh weight; bFC, fold change compared to GFP-δTIP; cFAA, total 19 free amino acids without cysteine.](elife-50747-fig2){#fig2}

*eva1* plants over-accumulate val {#s2-2}
---------------------------------

The role of IPMS1 in BCAA biosynthesis has been well characterized as directing flux towards Leu biosynthesis, and away from the competing product Val ([@bib78]; [@bib16]; [@bib24]) ([Figure 2a](#fig2){ref-type="fig"}). The Arabidopsis genome encodes two IPMS isoforms: IPMS1 mRNA accumulates to higher levels than IPMS2 mRNA through most stages of plant growth ([@bib16]). An earlier work examined two-week old plants and found that Val and Ile were increased in both *ipms1-4* and *ipms1-5* but Leu was decreased in *ipms1-4* and increased in *ipms1-5* ([@bib78]). To determine the impact of the *eva1* mutation on amino acid homeostasis at earlier stages of growth, we conducted free amino acid analysis of 10- and 20 day old WT and *ipms1* mutants. Notably, we found that *eva1*, *ipms1-4* and *ipms1-5* had similar increases in Val and total BCAAs and decreases in Leu, consistent with our findings that *eva1* is a loss-of-function allele of *IPMS1* ([Figure 2b,c](#fig2){ref-type="fig"}; [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}). In addition, in these mutants we found similar changes of Asp-derived amino acids (threonine-Thr, methionine-Met, lysine-Lys and Ile) and aromatic amino acids (phenylalanine-Phe, tryptophan-Trp and tyrosine-Tyr) ([Figure 2b,c](#fig2){ref-type="fig"}). Consistent with a disappearance of the subcellular phenotypes of the mutants during growth ([Figure 1a - d](#fig1){ref-type="fig"}), the impact of *ipms1* mutations on amino acid homeostasis was mitigated at 20 days of growth, with the fold change of Val becoming smaller in the mutants *versus* WT, and the types of amino acids significantly changed in the mutants compared to WT becoming fewer ([Figure 2b,c](#fig2){ref-type="fig"}). Taken together, these data indicate that *eva1* is a loss-of-function mutant of *IPMS1* equivalent to *ipms1-4* and *ipms1-5* and that the alteration in BCAA levels is most notable for increased in Val levels.

Disruption of BCAA homeostasis leads to pleiotropic defects in plant growth and development {#s2-3}
-------------------------------------------------------------------------------------------

Next, we asked whether the transient changes in BCAA accumulation and vacuole morphology affected early plant growth. At 10 days following germination, the *IPMS1* loss-of-function mutants displayed retardation of growth and development ([Figure 1g,h](#fig1){ref-type="fig"}), showing approximately 30--40% decrease in aerial tissue fresh weight and 40--50% decrease in primary root length compared to WT ([Figure 3---figure supplement 1a,b](#fig3s1){ref-type="fig"}). Propidium iodide staining showed a strikingly delayed formation of root hairs in *ipms1* mutants compared to WT ([Figure 3---figure supplement 2a](#fig3s2){ref-type="fig"}), which was accompanied by increases in both cell length and number in the elongation zone ([Figure 3---figure supplement 2b,c](#fig3s2){ref-type="fig"}). Meanwhile, in *ipms1* meristem has increased cell number but reduced cell length ([Figure 3---figure supplement 2c,d](#fig3s2){ref-type="fig"}). At 20 days of growth, the difference in fresh weight between *ipms1* alleles and WT became not significant, though the primary roots of the *ipms1* mutants were still slightly shorter than WT ([Figure 3---figure supplement 1c,d](#fig3s1){ref-type="fig"}). In contrast, two independent lines of dominant *ipms1-1D* feedback-insensitive mutant, which have small Val decrease and Leu increase ([@bib78]), exhibited indistinguishable primary root elongation, but increased fresh weight compared to WT ([Figure 3---figure supplement 1a--d](#fig3s1){ref-type="fig"}). Additionally, we did not observe notable difference between six-week old WT and *IPMS1* loss-of-function mutants growing in soil ([Figure 3---figure supplement 1e](#fig3s1){ref-type="fig"}). The transient retardation of overall plant growth of *IPMS1* loss-of-function mutants correlated with the emergence-and-disappearance period of both vacuole morphology and BCAA homeostasis perturbation phenotypes ([Figure 1a - d](#fig1){ref-type="fig"}; [Figure 2b,c](#fig2){ref-type="fig"}).

We then examined the development of cotyledons, which constituted most of the aerial tissue for amino acid profiling and were used for confocal microscopy analyses. Cotyledons of *ipms1* mutants were thicker and larger than WT ([Figure 3a - c](#fig3){ref-type="fig"}). Despite a delay of true leaf emergence ([Figure 1g](#fig1){ref-type="fig"}), the expanded first pair of true leaves in these mutants were larger than WT ([Figure 1h](#fig1){ref-type="fig"}). Analyses of chloroplast ultrastructure revealed an absence of connecting stroma thylakoids and a reduction of thylakoid length *ipms1* alleles compared to WT ([Figure 3d,e](#fig3){ref-type="fig"}). Additionally, we noticed purple pigmentation in 10 day old *IPMS1* loss-of-function mutants, particularly in cotyledon petioles and emerging true leaves ([Figure 3---figure supplement 3a](#fig3s3){ref-type="fig"}). Anthocyanin extraction and measurement confirmed that these mutants contained higher levels of total anthocyanins compared to WT ([Figure 3---figure supplement 3b,c](#fig3s3){ref-type="fig"}). These results indicate that the growth of certain tissues of the *ipms1* mutants is particularly promoted but the overall plant growth and development are temporarily inhibited.

![Mutants of *IPMS1* show defects in cotyledon architecture and chloroplast ultrastructure.\
(**a**) Light microscopic images of cotyledon cross sections. Cotyledon thickness is denoted by red lines. Scale bar, 100 μm. (**b**) Measurement of cotyledon thickness. n = 9 for WT, *eva1* and *ipms1-4;* n = 6 for *ipms1-5*. (**c**) Measurement of cotyledon size. n = 20 for each genotype. (**d**) Representative transmission electron microscopy images of chloroplasts. Arrows point to connecting stroma thylakoids that are existing in WT and absent in mutants. Scale bar, 0.5 μm. (**e**) Measurement of thylakoid length. Five cotyledons from each genotype were sampled for imaging, and at least 30 stroma thylakoids were measured in each sample (n ≥ 150). For all graphical representations of data, columns are mean ± SD. The asterisks indicate significant differences of each mutant compared to wild type (\*\*\*p≤0.001, \*\*p≤0.01, unpaired *t* test).](elife-50747-fig3){#fig3}

The organization of ER network and actin cytoskeleton is altered in *eva1* {#s2-4}
--------------------------------------------------------------------------

To gain more insights into the *eva1* vacuolar phenotypes, we extended our analyses to other endomembrane compartments. The endoplasmic reticulum (ER) is the most extensively distributed organelle of the plant secretory pathway, and it is closely associated with several other membrane-bound organelles, including the vacuole ([@bib71]). In the *eva1* mutant, the ER luminal marker ERYK ([@bib47]) revealed a pronounced appearance of the cortical ER network with strikingly thickened strands compared to WT ([Figure 4a](#fig4){ref-type="fig"}; see arrows). The thickened ER strands did not completely overlap with the TVSs ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). High-magnification confocal microscopy images of the cortical ER revealed a pronounced cisternation in *eva1* compared to WT ([Figure 4b](#fig4){ref-type="fig"}). Quantitative analyses of the surface area occupancy of the ER in the total field of view confirmed these observations (i.e., larger ER-occupied area in *eva1* compared to WT) ([Figure 4d](#fig4){ref-type="fig"}). The appearance of the Golgi apparatus, which in plant cells is organized in disperse stacks of cisternae in close association with the ER ([@bib7]), also was abnormal. Indeed, the Golgi marker GFP-CASP ([@bib52]) revealed increased clustering and higher abundance of Golgi stacks at the cell cortex in *eva1* compared to WT ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Next, we examined secretion to the apoplast with the bulk flow marker SEC-RFP ([@bib22]). We found no intracellular retention of the marker in *eva1* ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}), as it would be expected for mutants with defects in secretion, an important function of the endomembrane system ([@bib53]; [@bib54]). These results and the absence of retention of the vacuolar marker in the ER ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) document that the morphology of the vacuole, organization of the Golgi and the ER network are markedly affected by the *eva1* mutation, while bulk-flow secretion is unaffected.

![Mutation of *IPMS1* affects the ER morphology and the F-actin organization.\
(**a** and **b**) Confocal images of the wild type and *eva1* cotyledon epidermal cells expressing ER marker ERYK. (**a**) Low-magnification Z-stack projection images show the ER morphology in *eva1* is altered, featuring longer and more thickened ER strands, as the arrows indicate. Scale bar, 50 μm. (**b**) High-magnification single-plane images show enlarged ER sheets in *eva1* mutant. Scale bar, 10 μm. (**c**) Confocal images of the wild type and *eva1* cotyledon epidermal cells expressing F-actin marker YFP-ABD2. Scale bar, 50 μm. **d**), Quantification of ER occupancy, which measures the percentage of the area occupied by ER in the total field of view (n = 20 for each genotype). Single-plane images were used for the quantification. Columns show mean ± SD. The asterisks indicate significant differences (\*\*p≤0.01, unpaired *t* test). (**e** and **f**) Quantitative evaluation of the F-actin organization using two parameters. Quantification of skewness (**e**) indicates higher level of F-actin bundling in *eva1* compared to wild type (n = 32 for each genotype); measurement of density (**f**) percentage suggests lower occupancy of F-actin in *eva1* compared to wild type (n = 28 for each genotype). Z-stack projection images were used for the quantification. Columns show mean ± SD. The asterisks indicate significant differences (\*\*p≤0.01 and \*\*\*p≤0.001, unpaired *t* test).](elife-50747-fig4){#fig4}

Collectively, the root-related defects of the *ipms1* mutants, including delayed formation of root hairs and reduced number of lateral roots ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}; [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}), are reminiscent of mutants with impaired actin depolymerization or promoted actin bundling ([@bib32]; [@bib17]), consistent with the possibility that reorganization of actin cytoskeleton may be causative of the observed developmental phenotypes. Furthermore, because the establishment and maintenance of the TVSs, ER network and Golgi subcellular distribution are dependent on the actin cytoskeleton ([@bib71]), we hypothesized that the organization of actin cytoskeleton may be altered in *eva1*. Indeed, confocal microscopy in cells expressing the actin filament (F-actin) marker YFP-ABD2 ([@bib65]) revealed coalescence of actin cables compared to WT ([Figure 4c](#fig4){ref-type="fig"}). Furthermore, quantitative analyses of actin organization identified higher skewness, suggesting enhanced bundling, and lower density, suggesting decreased occupancy of F-actin in the cytoplasm in *eva1* compared to WT ([Figure 4e,f](#fig4){ref-type="fig"}). These results imply that the prominent phenotypes of the endomembranes in *eva1* may be due to their connections with F-actin, whose organization is largely altered in the *eva1* mutant.

We next sought to validate this hypothesis by testing the sensitivity of the *ipms1* alleles to the F-actin depolymerizing reagent latrunculin B (Lat B) ([@bib10]). The primary root length of 10 day old *ipms1-4* and *ipms1-5* was approximately 50% of WT ([Figure 4---figure supplement 4a,c](#fig4s4){ref-type="fig"}). Seedlings of all genotypes were then transferred to medium containing DMSO or 50 nM or 100 nM Lat B in DMSO. After another 8 days, we found that the Lat B treatment promoted the formation of lateral roots in WT seedlings, but not in *ipms1* alleles ([Figure 4---figure supplement 4b](#fig4s4){ref-type="fig"}). Additionally, the primary root length of *ipms1-4* and *ipms1-5* was approximately 65% compared to WT on DMSO medium; however, this difference was reduced in the presence of increasing levels of Lat B in the growth medium (i.e., 80% to WT on 50 nM Lat B, and not significantly different from WT on 100 nM Lat B) ([Figure 4---figure supplement 4d](#fig4s4){ref-type="fig"}). These results demonstrate that the *ipms1* alleles are less sensitive to F-actin depolymerization compared to WT, supporting a functional connection between the disruption of *IPMS1* and altered organization of the actin cytoskeleton.

The *eva1* vacuolar phenotypes are rescued by PI3K/TOR dual inhibitors and partially recovered by disruption of F-actin {#s2-5}
-----------------------------------------------------------------------------------------------------------------------

To gain insights into the mechanisms by which *eva1*defects in BCAA biosynthesis led to alteration of the organization of subcellular structures, we employed chemicals known to alter the vacuolar morphogenesis and cytoskeleton integrity. We hypothesized that the persistence of small vacuoles in *eva1* could be due to delayed vacuole membrane fusion during vacuole morphogenesis. To test this, we first employed wortmannin (Wm), an inhibitor of phosphoinositide 3-kinases (PI3Ks) that disrupts the balance of phosphoinositides and promotes homotypic tonoplast fusion ([@bib86]; [@bib72]; [@bib43]). We found that treatment of 10 day old WT and *eva1* seedlings for two hours suppressed the *eva1* phenotypes ([Figure 5a - d](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). The effects of Wm were mirrored by treatment with another PI3K inhibitor, LY294002 ([@bib86]) ([Figure 5---figure supplement 1e--h](#fig5s1){ref-type="fig"}). We then investigated a relationship between TVSs and integrity of the cytoskeleton in *eva1*. After a two-hour treatment with Lat B, we found that TVSs disappeared but the small vacuoles persisted in *eva1* cotyledon epidermal cells ([Figure 5e,f](#fig5){ref-type="fig"}). By contrast, a two-hour treatment with oryzalin, a microtubule disrupting reagent ([@bib86]), did not lead to discernable change of vacuole morphology ([Figure 5g,h](#fig5){ref-type="fig"}). Together these results indicate that the presumably unfused vacuole and enhanced TVS phenotypes in *eva1* are both responsive to Wm and LY294002, but only the enhanced TVS phenotype is related to the verified reorganization of F-actin.

![Chemical interventions can fully or partially rescue the vacuolar mutant phenotypes of *eva1*.\
(**a -- h**) Confocal images of cotyledon epidermal cells expressing GFP-δTIP from 10 day old *eva1* plants. Images were acquired after 2 hr treatment of DMSO (**a and b**), wortmannin (Wm; **c and d**), latrunculin B (Lat B; **e and f**), or oryzalin (**g and h**). The top panel (**a**), (**c**), (**e**, and **g**) presents images of lower magnification with a scale bar of 50 μm. The bottom panel (**b**), (**d**), (**f**, and **h**) presents images of higher magnification with a scale bar of 10 μm. Arrowheads suggest presumably unfused vacuolar structures and arrows pinpoint enhanced TVSs. All the images are Z-stack maximal projections.](elife-50747-fig5){#fig5}

Loss of function of IPMS1 leads to up-regulation of TOR activity {#s2-6}
----------------------------------------------------------------

Through chemical interventions, we confirmed that homotypic membrane fusion and F-actin bundling are two processes directly involved in the *eva1* Leu biosynthetic mutant phenotypes ([Figure 5](#fig5){ref-type="fig"}). This creates a quandary given that the role of IPMS1 in chloroplast BCAA biosynthesis is both functionally disconnected with -- and spatially isolated from -- the endomembrane compartments and actin cytoskeleton. Although the functions of Wm and LY294002 in inhibiting PI3Ks and promoting homotypic vacuolar membrane fusion have been established in plant cells ([@bib14]; [@bib86]; [@bib72]; [@bib42]), in mammalian cell studies these chemicals have been used to inhibit TOR signaling ([@bib58]; [@bib8]). This is because TOR belongs to the phosphoinositide kinase-related kinase (PIKK) family, whose members share similar kinase domains with PI3Ks ([@bib2]). Indeed, Wm and LY294002 are effective inhibitors of mammalian TOR ([@bib8]), and thus are considered as PI3K/TOR dual inhibitors ([@bib5]). These considerations and our results led us to hypothesize that the effects of Wm and LY294002 in suppressing the *eva1* vacuole phenotypes could be related to TOR inhibition.

To test this hypothesis, we employed two TOR inhibitors with high selectivity for TOR over PI3Ks: AZD-8055 and Torin2 ([@bib5]; [@bib37]; [@bib12]), which also effectively inhibit plant TOR ([@bib36]; [@bib73]; [@bib20]; [@bib50]). We transferred 10 day old WT and *eva1* seedlings to liquid growth medium containing 5 μM AZD-8055. Compared to untreated samples, WT cells did not exhibit significant changes in the morphology of the central vacuole and the few thin TVSs after 2 or 4 hr of incubation, although numerous fluorescent punctae appeared ([Figure 6a,c,e](#fig6){ref-type="fig"}). Because TOR is the major negative regulator of autophagy ([@bib50]), the punctae are presumably autophagic structures resulting from the TOR inhibition by the chemicals. Untreated *eva1* cells contained numerous small vacuoles and conspicuous TVSs ([Figure 6b](#fig6){ref-type="fig"}); however, by 2 hr treatment with AZD-8055, these structures were reduced in appearance ([Figure 6d](#fig6){ref-type="fig"}). By 4 hr treatment, the *eva1* cells were indistinguishable from WT, including the appearance of the small punctae ([Figure 6e,f](#fig6){ref-type="fig"}). These results were mirrored by Torin2 treatment: presumably unfused vacuoles and TVSs were no longer present in the *eva1* cells by 2 hr of 1 μM Torin2 treatment ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). This result is in line with the higher in vitro TOR inhibitory activity of Torin2 compared to AZD-8055 ([@bib37]; [@bib12]). In addition to the effects of temporal treatment on vacuolar phenotype ([Figure 6g](#fig6){ref-type="fig"}), we tested the effects of chronical inhibition of TOR. We found *ipms1* primary root elongation was promoted by lower concentrations (0.1 and 0.2 μM), but inhibited by higher concentrations (0.4, 0.6 and 1.0 μM) of AZD-8055 ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}), suggesting moderate TOR inhibition led to optimized plant growth of *ipms1*. Similarly, a low concentration of wortmannin caused minimal but significant promotion of *ipms1* root elongation ([Figure 6---figure supplement 3a--c](#fig6s3){ref-type="fig"}). By comparison, promotion of root elongation was not observed upon Lat B treatment ([Figure 6---figure supplement 3d--f](#fig6s3){ref-type="fig"}). Together these results indicate that both subcellular and growth defects of *ipms1* are associated with up-regulated TOR and are suppressed by TOR inhibition.

![Vacuolar mutant phenotypes of *eva1* are correlated with up-regulated TOR activity.\
(**a -- f**) TOR inhibitor AZD-8088 treatment rescues vacuolar mutant phenotypes of *eva1*. Confocal images were acquired before (**a and b**), after 2 hr (**c and d**), and after 4 hr (**e and f**) 5 μM AZD-8055 treatment of wild type and *eva1* mutant. Arrowhead indicates presumably unfused vacuolar structures and arrows point to enhanced TVSs. All the images are Z-stack maximal projections. Scale bar, 25 μm. (**g**), Quantification of presumably unfused vacuoles in *eva1* before and after TOR inhibitor treatment. Values are mean ± SD. The asterisks indicate significant differences (n = 30 cells for each treatment; \*\*\*p≤0.001, NS, p\>0.05 and not significant, unpaired *t* test). (**h**) Immunoblotting detected phosphorylation of S6K by TOR, using specific antisera against S6K-phosphorylated and S6K. LC, loading control with Ponceau S staining. (**i**) S6K phosphorylation status calculated by the ratio of S6K-p/S6K in fold change compared to wild type. n = 3 and values are mean ± SEM (\*\*\*p≤0.05, unpaired *t* test). (**j**) EdU staining detected root meristem activity of 10 day old seedlings. For each genotype, an image of green pseudocolor shows EdU-stained newly synthesized DNA and a bright-field image shows structure of root tip. Scale bar, 100 μm. (**k**) Quantification of EdU fluorescence intensity. Values are mean ± SD. The asterisks indicate significant differences compared to wild type (n = 9 for each genotype; \*\*p≤0.01, \*\*\*p≤0.001, unpaired *t* test).](elife-50747-fig6){#fig6}

We next sought to confirm these results by testing the activation status of TOR in *ipms1*. Based on the evidence that TOR inhibition rescued the *ipms1* subcellular phenotypes, we predicted to find an increased level of TOR activity in *ipms1* compared to WT. S6K is a conserved substrate of TOR protein kinase and its phosphorylation status has been adopted as an indicator of TOR activity in plants ([@bib49]; [@bib73]; [@bib20]; [@bib81]). Indeed, immunoblot analyses with specific antisera for either phosphorylated or total S6K ([@bib49]; [@bib73]; [@bib20]; [@bib81]) revealed increased levels of TOR-phosphorylated S6K in *eva1* and *ipms1-4* compared to WT, despite similar levels of total S6K in three genotypes ([Figure 6h,i](#fig6){ref-type="fig"}). These data supports that TOR signaling is up-regulated in the *ipms1* background. To validate this conclusion, we monitored DNA synthesis in root tips because a stimulated TOR signaling promotes cell proliferation in the root apical meristem, which can be detected by EdU staining of newly synthesized DNA ([@bib36]; [@bib20]; [@bib79]). Consistent with our hypothesis, the EdU staining displayed enhanced labeling in the root apical meristem of *ipms1-4* and *ipms1-5* compared to WT ([Figure 6j,k](#fig6){ref-type="fig"}). This result was supported by propidium iodide staining and morphometric analyses of root tips showing increased cell numbers in the root apical meristem of *eva1*, *ipms1-4* and *ipms1-5* compared to WT ([Figure 3---figure supplement 2c](#fig3s2){ref-type="fig"}).

Taken together, the results indicating suppression of vacuole phenotypes by TOR inhibition, increased levels of S6K phosphorylation and root apical meristem activity (i.e., increased DNA synthesis and cell number) in the *ipms1* mutants support the hypothesis that TOR signaling is up-regulated in the *IPMS1* loss-of-function mutants.

Over-accumulation of BCAAs alters the subcellular organization of the actin cytoskeleton and endomembranes {#s2-7}
----------------------------------------------------------------------------------------------------------

Furthermore, we aimed to test a role of TOR signaling and its specificity in the verified BCAA over-accumulation-induced phenotypes. To do so, we utilized an estradiol-inducible TOR mutant (*tor-es*) ([@bib81]) and a loss-of-function mutant of *AtRAPTOR1B* (*raptor1b*, SALK_022096) ([@bib56]), a locus encoding the functional TORC1 component RAPTOR in Arabidopsis ([@bib57]; [@bib1]). Before silencing induction, similar to WT ([Figure 7a,e](#fig7){ref-type="fig"}), *tor-es* seedlings grown on BCAA-supplemented medium showed induced F-actin bundling compared to *tor-es* grown on normal medium ([Figure 7b,f](#fig7){ref-type="fig"}). After induction of TOR silencing, *tor-es* grown on either medium exhibited similarly low levels of bundling ([Figure 7c,g](#fig7){ref-type="fig"}). These results confirm a functional dependence of TOR signaling and the actin cytoskeleton phenotype due to mis-regulated TOR. By contrast, in *raptor1b* BCAA feeding led to F-actin bundling ([Figure 7d,h](#fig7){ref-type="fig"}). Together, these results not only indicate that reorganization of F-actin induced by over-accumulation of BCAAs is dependent on functional TOR but also underlie a cause of the subcellular phenotype linked to BCAA on TOR signaling components other than RAPTOR.

![Feeding of exogenous BCAAs and over-a﻿ccumulation of endogenous BCAAs induce actin bundling, which is dependent on functional TOR but not RAPTOR.\
Organization of actin cytoskeleton presented by confocal images of cotyledon epidermal cells expressing F-actin marker YFP-ABD2. Higher fluorescence intensity of the actin marker suggests more bundling of actin filaments. Using ImageJ, we drew a 50 μm red arrowed line to detect the pixel fluorescence intensity beneath such a line. In each image, the red arrowed line is positioned where we detected the highest fluorescence intensity using non-saturating imaging settings. A chart beneath the image presents plotted fluorescence intensity along the red arrowed line. Without actin bundling, fine actin filaments have fluorescence intensity about 1000 (relative unit). In contrast, induced actin bundling show fluorescence intensity peaks of 3000--4000 (relative unit). (**a -- d**) Without feeding of BCAAs (mock), wild type, *tor-es* with or without silencing, and *raptor1b* did not show induced actin bundling. (**e -- h**) Feeding of 1 mM BCAAs induced striking actin bundling in wild type, *tor-es* without gene silencing and *raptor1b* (**e, f, h**), but not in *tor-es* with induction of TOR silencing (**g**). (**i -- l**), Without feeding of BCAAs (mock), mutants with small changes of BCAAs did not show induced actin bundling (**i and j**); mutants with over-accumulation of endogenous BCAAs showed induced actin bundling (**k and l**). All the images are Z-stack maximal projections. Scale bars, 50 μm.](elife-50747-fig7){#fig7}

Next, we aimed to test the generality of the connection between over-accumulation of BCAAs, morphological alteration of cellular structures and functional TOR signaling. To do so, we used a variety of previously characterized BCAA mutants ([@bib78]), combined with BCAA feeding. For example, *ipms1-1^D^* was chosen because it has a modest Val decrease and Leu increase; *ahass1-1* has a small Val increase; *ahass2-7* has decreased Val and Leu; *omr1-11^D^* has a \> 140 fold Ile increase compared to WT. Confocal microscopy analyses of cotyledon epidermal cells revealed that the organization of F-actin in *ipms1-1^D^* and *ahass1-1* mutants resembled that of WT ([Figure 7a,i and j](#fig7){ref-type="fig"}). By contrast, enhanced actin bundling was observed following BCAA feeding (1 mM Val, Leu and Ile) and in the *ipms1-5* and *omr1-11^D^* mutants ([Figure 7e,k and l](#fig7){ref-type="fig"}). Interestingly also, we found that the mutants showed reorganization of F-actin and remodeling of the ER network. Specifically, mutants with moderate increase or decrease in BCAAs showed ER morphology similar to WT ([Figure 7---figure supplement 1a--d](#fig7s1){ref-type="fig"}), while WT grown with BCAA supplementation and mutants that over-accumulate BCAAs showed compromised ER organization with longer and thicker ER strands compared to WT ([Figure 7---figure supplement 1e--g](#fig7s1){ref-type="fig"}). The striking phenotype of enhanced ER strands in *omr1-11^D^* was recovered by a 2 hr Torin2 treatment ([Figure 7---figure supplement 1h](#fig7s1){ref-type="fig"}). In addition to bundling of F-actin and enhancement of ER strands, supplementation of BCAAs also induced the formation of prominent TVSs ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Together, these results support a general correlation between over-accumulation of BCAAs and distorted actin cytoskeleton and endomembranes.

Discussion {#s3}
==========

In eukaryotic cells, the TOR kinase coordinates cell growth and metabolism with nutrient sensing ([@bib59]; [@bib34]). In mammalian cells, the availability of BCAAs and other amino acids -- as well as glucose and mammalian growth factors -- regulates TOR signaling, which generally promotes growth via several downstream cellular processes, including mRNA translation, metabolism of nucleotides, sugar and lipids, protein turnover and cytoskeletal reorganization ([@bib59]; [@bib34]). Prior to this work, in plant cells a functional connection between glucose availability and TOR activation had been established ([@bib66]). Besides, a recent research found that mutation of IPMS1 leads to alteration of Leu biosynthesis and reduced sensitivity to TOR inhibition ([@bib60]), but a role for BCAA homeostasis in TOR signaling was yet unknown. Furthermore, it was still unclear whether TOR signaling is connected to the morphogenesis and remodeling of subcellular structures, other than autophagic bodies. We demonstrated that TOR signaling senses BCAA homeostasis and modulates the organization of subcellular structures, including actin cytoskeleton and endomembranes. Indeed, we provide evidence that over-accumulation of BCAAs up-regulates TOR signaling, inducing actin bundling with formation of aberrant endomembrane structures and compromising overall growth ([Figure 8](#fig8){ref-type="fig"}).

![Working model of TOR-regulated subcellular processes.\
Over-accumulation of BCAA Val, Leu and Ile stimulates TOR signaling. Except for the established downstream processes such as protein synthesis and cell proliferation, vacuole fusion and actin reorganization are indicated also regulated by TOR signaling, but the underlying mechanisms are unclear. Reorganization of the actin cytoskeleton is independent of TORC1, and prominent *trans*-vacuolar strands and ER strands are subsequently formed due to the strong interactions between the endomembranes and the F-actin in plant cells.](elife-50747-fig8){#fig8}

Endogenous BCAAs influence TOR signaling in plant cells {#s3-1}
-------------------------------------------------------

In yeast and mammalian cells, TOR signaling is modulated directly by changes in amino acid levels, especially BCAAs, and indirectly by glucose levels and growth factors ([@bib59]; [@bib34]). In plants, TOR-mediated meristem activation by sugar and light signals has been established ([@bib36]; [@bib11]; [@bib49]; [@bib79]). In addition, a recent research suggested a connection between IPMS1-regulated Leu biosynthesis and TOR signaling ([@bib60]). Specifically, this work identified another *IPMS1* mutant allele *rol17* with shorter primary root, and its primary root elongation is hyposensitive to TOR inhibitor treatment ([@bib60]). Considering that plants produce BCAAs de novo and their biosynthesis is stringently controlled ([@bib78]), it is necessary to explore a general connection between TOR signaling and amino acid homeostasis.

In this study, using a series mutants of BCAA biosynthesis, exogenous feeding of BCAAs and mutants of TOR signaling, we provide evidence for a functional correlation between BCAA accumulation and TOR activity in plant cells. Indeed, we found that in early stage of growth (i.e., 10 days) BCAA over-accumulating mutants showed up-regulation of TOR, a phenotype that was recreated by BCAA feeding. Furthermore, a reduction in TOR signaling activation via dual and specific TOR inhibitors restored the actin and endomembrane phenotypes. Our results establish that plant TOR senses over-accumulation of BCAAs, and that up-regulation of TOR signaling alters the organization of actin cytoskeleton and associated endomembranes and controls plant growth. Our results indicate that plant TOR signaling and TOR-dependent growth regulation are highly responsive to BCAA availability, at least in early stages of growth, underscoring a previously unappreciated but significant role of these amino acids in TOR biology.

TOR signaling controls actin organization in plant cells {#s3-2}
--------------------------------------------------------

In yeast and mammalian cells, a reorganization of actin cytoskeleton was the first identified downstream effect specific to TORC2, which was also found to be independent of TORC1 ([@bib58]; [@bib31]; [@bib64]). The yeast and mammalian TORC2 phosphorylates other protein kinases, which signal to the Rho-coordinated cytoskeletal signaling ([@bib77]; [@bib55]). Recently, it has been demonstrated that Arabidopsis ROP2 interacts with TOR and mediates an auxin-to-TOR signaling ([@bib36]; [@bib61]), suggesting an interplay among TOR, ROPs and the cytoskeleton in plant cells. In terms of TORC2 activation, in mammalian cells, Rictor and mTOR, but not Raptor, are required for PKC phosphorylation and actin organization ([@bib58]), and nutrient repletion after starvation stimulates actin organization ([@bib31]). Nevertheless, much less is known about the activation mechanism of mTORC2 than that of mTORC1. Therefore, how BCAAs activate a potential TORC2 in plant cells is still an open question ([Figure 8](#fig8){ref-type="fig"}). The evidence provided in our work for promoted actin bundling phenotype in mutants with BCAA over-accumulation or upon BCAA supplementation to WT provides direct support for a functional interaction between TOR and the actin cytoskeleton. Furthermore, our evidence that the BCAA-induced actin reorganization relies on functional TOR but not RAPTOR, which defines TORC1, extends these conclusions at a mechanistic level about the exclusive functions of TOR interactors and specific downstream processes.

Plant endomembrane homeostasis is correlated with TOR activity {#s3-3}
--------------------------------------------------------------

In this work, we have shown that an over-accumulation of BCAAs affects the morphology of the tonoplast, ER and Golgi distribution. Our results also showed that attenuation of TOR signaling in BCAA over-accumulating mutants leads to a restoration of the defective actin cytoskeleton and endomembrane morphology. We propose therefore that in plant cells a stringent relationship exists between endomembrane organization and TOR-signaling, which occurs via a functional connection of TOR with the actin cytoskeleton. Depending on nutrient status, TORC1 regulates the size and number of yeast vacuoles and mammalian lysosomes ([@bib82]; [@bib44]). In light of the conserved functions of nutrient storage and turnover that are shared by plant and yeast vacuoles ([@bib83]), a TORC1-dependent control of the vacuolar homeostasis may be conserved in plant cells. An auxin-dependent actin remodeling has been also recently invoked in controlling vacuole occupancy in the plant cell ([@bib38]; [@bib62]). Additionally, a recent work reported regulation of vacuole expansion by extracellular LRX ([@bib21]), whose mutation resulted in root hair defects that can be suppressed by mutation of IPMS1 ([@bib60]). In this work, we provided evidence for a remodeling of actin through TORC1-independent TOR signaling. Therefore, we propose that TOR activity is involved in morphogenesis of the central vacuole, but this may occur through mechanisms that are not conserved ([Figure 8](#fig8){ref-type="fig"}).

Plant growth and TOR signaling {#s3-4}
------------------------------

BCAAs are crucial nutrients that humans and other animals must obtain from diets. Significant deficits exist in the amino acid composition of plant feed sources for livestock ([@bib6]). Moreover, BCAAs serve as human dietary supplements, because they potently promote protein synthesis through TOR activity ([@bib67]). Fortification of crops with BCAAs is therefore desirable to improve plant nutritional content. However, studies in Arabidopsis reported that BCAA over-accumulation due to exogenous feeding or genetic manipulation of biosynthetic or catabolic pathways resulted in various defects in plant growth and development ([@bib78]; [@bib48]; [@bib25]; [@bib30]). In this study, we established a functional connection between BCAA over-accumulation and plant growth inhibition, which is likely linked to alteration of TOR signaling and disruption of subcellular structures. Despite an overall retardation of early plant development compared to WT, *ipms1* seedlings exhibited up-regulation of the growth-promoting TOR signaling in concert with locally promoted growth, such as larger and thicker cotyledons and higher activity of root apical meristem. At the subcellular level, we showed that BCAA over-accumulation via exogenous feeding or genetic mutations caused severe remodeling of the actin cytoskeleton and endomembranes, which underlies certain growth defects such as delayed formation of root hairs and reduced abundance of lateral roots ([@bib68]; [@bib32]; [@bib17]). In addition, *ipms1* mutants show increase in leaf thickness and alteration of chloroplast ultrastructure, which is similar to a knockdown mutant of isopropylmalate isomerase (IPMI), the enzyme following IPMS for Leu biosynthesis ([@bib30]), suggesting an association of BCAA accumulation with defective chloroplast development. Together, our results indicate that an inconsistency between nutrient status and the activity of metabolic signaling is detrimental to plant growth and development. By adding new insights into the fundamental understanding of plant growth control by metabolic signaling, our study supports that developmentally controlled manipulation of TOR signaling may be required for successful engineering of crops with improved yield and nutritional values.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                              Designation                                    Source or\      Identifiers          Additional information
  (species) or\                                                                             reference                            
  resource                                                                                                                       
  ------------------------------------------ ---------------------------------------------- --------------- -------------------- -------------------------------------
  Gene (*Arabidopsis thaliana*)              *AtIPMS1*                                                      TAIR: AT1G18500      

  Gene (*Arabidopsis thaliana*)              *AtOMR1*                                                       TAIR: AT3G10050      

  Gene (*Arabidopsis thaliana*)              *AtAHASS1*                                                     TAIR: AT2G31810      

  Gene (*Arabidopsis thaliana*)              *AtAHASS2*                                                     TAIR: AT5G16290      

  Gene (*Arabidopsis thaliana*)              *AtTOR*                                                        TAIR: AT1G50030      

  Gene (*Arabidopsis thaliana*)              *AtRaptor1B*                                                   TAIR: AT3G08850      

  Genetic reagent (*Arabidopsis thaliana*)   *eva1*                                         this paper                           EMS line with a mutation of *IPMS1*

  Genetic reagent (*Arabidopsis thaliana*)   *ipms1-4*                                      [@bib78]        SALK_101771          

  Genetic reagent (*Arabidopsis thaliana*)   *ipms1-5*                                      [@bib78]        WiscDsLoxHs221_05F   

  Genetic reagent (*Arabidopsis thaliana*)   *tfl111 (ipms1-1^D^)*                          [@bib78]        TAIR: CS69734        

  Genetic reagent (*Arabidopsis thaliana*)   *tfl102 (ipms1-1^D^)*                          [@bib78]        TAIR: CS69733        

  Genetic reagent (*Arabidopsis thaliana*)   *ahass1-1*                                     [@bib78]        SALK_096207          

  Genetic reagent (*Arabidopsis thaliana*)   *ahass2-7*                                     [@bib78]        WiscDsLoxHs009_02G   

  Genetic reagent (*Arabidopsis thaliana*)   *ahass2-1^D^*                                  [@bib78]        TAIR: CS69724        

  Genetic reagent (*Arabidopsis thaliana*)   *omr1-11^D^*                                   [@bib78]        TAIR: CS69720        

  Genetic reagent (*Arabidopsis thaliana*)   *tor-es*                                       [@bib81]        TAIR: CS69829        

  Genetic reagent (*Arabidopsis thaliana*)   *raptor1b*                                     [@bib56]        SALK_022096          

  Antibody                                   Anti-S6K (Rabbit polyclonal)                   Agrisera        AS12 1855            Western blotting (1:1000 dilution)

  Antibody                                   Anti-S6K-phosphorylated (Rabbit polyclonal)    Abcam           ab207399             Western blotting (1:1000 dilution)

  Antibody                                   HRP conjugated anti-rabbit (Goat polyclonal)   Sigma-Aldrich   A0545                Western blotting (1:10000 dilution)

  Commercial assay or kit                    Click-iT EdU Alexa Fluor 488 Imaging Kit       Invitrogen      C10337               
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

Plant materials and growth conditions {#s4-1}
-------------------------------------

An EMS mutant line first identified in a screen for vacuolar phenotypes ([@bib4]) was crossed with wild type (Col-0) for three times to obtain a progeny with consistently inherited vacuolar and growth phenotypes, which was designated as *eva1*.

Except for chronical treatments with specified chemicals, Arabidopsis seeds were stratified and grown on medium containing half-strength Linsmaier and Skoog nutrients (½ LS; Caisson Labs, LSP03), 1% sucrose and 0.4% phytagel (Sigma-Aldrich, P8169) in chambers configured with 21°C and 16 hr light: 8 hr dark cycle.

To examine the effect of latrunculin B (Lat B) on root elongation ([Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}), wild type (Col-0), *ipms1-4* and *ipms1-5* lines germinated and grew on horizontally staged Petri dishes containing Arabidopsis growth medium (½ LS, 1% sucrose and 0.4% phytagel). 10 day old seedlings were transplanted to Petri dishes containing ½ LS, 1% sucrose and 1% Agar (Acumedia, 7558A) medium containing DMSO or 50 nM Lat B or 100 nM Lat B. Photographs were acquired immediately after the transplant and the Petri dishes were vertically staged in a Percival chamber. Photographs were also acquired 8 days after the transplant.

In another pharmaceutical examination using AZD-8055, wortmannin and Lat B ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}; [Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}), wild type (Col-0), *eva1*, *ipms1-4* and *ipms1-5* lines germinated and grew on vertically staged Petri dishes containing Arabidopsis growth medium containing specific chemical inhibitors.

Exogenous feeding of 1 mM BCAA was performed by stratification and germination of seeds on ½ LS, 1% sucrose and 1% Agar medium containing 1 mM equal concentrations of Ile, Val and Leu. L-Isoleucine (Sigma-Aldrich, I2752), L-Valine (Sigma-Aldrich, V0500) and L-Leucine (Sigma-Aldrich, L8000) were dissolved in water to prepare 1 M stock solutions, which were filtered by Millex-GS 0.22 µm filter units (Millipore, SLGS033SS).

Confocal microscopy {#s4-2}
-------------------

A Zeiss LSM 510 META and a Nikon A1Rsi laser scanning confocal microscope were used for imaging. Acquired images were handled by NIS-Elements Advanced Research (Nikon), ZEN (Zeiss) and Fiji (ImageJ) ([@bib63]). The fluorescent protein fusions used in this study are GFP-δTIP ([@bib15]), ERYK ([@bib47]), YFP-ABD2 ([@bib65]), GFP-CASP ([@bib52]), SEC-RFP ([@bib22]) and γTIP-YFP ([@bib47]). Transformation of Arabidopsis plants were conducted using floral dip method ([@bib13]).

Quantitative analysis of ER morphology and actin cytoskeletal organization {#s4-3}
--------------------------------------------------------------------------

Image acquisition and further evaluation of the ER cisternae was conducted using a previously described method ([@bib10]) that measures the occupancy of ER area in a region of interest. Analyses of the actin cytoskeletal organization were performed following a previously described procedure ([@bib39]). Briefly, Z-stack images with 0.5 μm intervals were acquired to cover the whole epidermal cell. The Z-stack series were converted to maximal projection images using NIS-Elements Advanced Research (Nikon) and Fiji (ImageJ) ([@bib63]). Utilizing two ImageJ macros that were previously generated ([@bib39]), skewness was measured to present the distribution of YFP-ABD2 fluorescence intensity and occupancy was measured for the density of skeletonized YFP-ABD2 fluorescence signal.

Chemical stocks and treatments {#s4-4}
------------------------------

All temporal chemical treatments were performed using 10 day old seedlings. Each of the following chemicals was first dissolved in DMSO to prepare a stock solution, and then diluted in Arabidopsis growth medium (½ LS and 1% sucrose) to reach the specific working concentration. 33 μM Wortmannin (Sigma-Aldrich, W1628) and 100 μM LY294002 (MedChemExpress, HY-10108) were used to treat seedlings for 2 hr. Latrunculin B (Sigma-Aldrich, L5288) and Oryzalin (Chem Service Inc, N-12729) were diluted to 25 μM and 40 μM, respectively, for 2 hr treatments. For TOR inhibition, seedlings were incubated with 5 μM AZD-8055 (MedChemExpress, HY-10422) or 1 μM Torin2 (MedChemExpress, HY-13002) for 2 or 4 hr as the figure legends indicated. 10 μM solution of β-estradiol (Sigma-Aldrich, E8875) was used to induce gene silencing.

Amino acid extraction and LC-MS/MS analysis {#s4-5}
-------------------------------------------

Plants used for amino acid extraction were grown under standard conditions for 10 or 20 days. The aerial tissue (fresh weight around 10 mg) was harvested into a 2 mL tube with two 3 mm steel beads and flash frozen in liquid N2. Tissue was either used immediately or stored at −80°C until extraction. Tissue was pulverized using a mixer mill (Retsch Mill, MM400) for 1 min at 30 times per second. Amino acids were extracted as previously reported ([@bib78]; [@bib3]). Briefly, an amino acid extraction buffer was prepared with \~2 μM heavy labeled amino acids standards (13C, 15N, Sigma-Aldrich), 10 μM 1,4-dithiothreitol (DTT, Sigma-Aldrich), and 10 mM perfluoroheptanoic acid (PFHA, Sigma-Aldrich). To the ground tissue, 350 μL of extraction buffer was added, vortexed for 10 s and heated at 90°C for 10 min. Tubes were cooled on ice for 5 min and centrifuged for 10 min at 4°C at 13,000 × g. The supernatant was applied to a low-binding hydrophilic 0.2 μm centrifugal polytetrafluoroethylene (PTFE) filter (Millipore, UFC30LG25) and centrifuged for 5 min at 3,500 × g. 150 μL flow through was transferred to 2 mL glass vials with glass insert for LC-MS analysis.

Amino acid detection and quantification by LC-MS/MS was performed as previously reported ([@bib78]; [@bib3]). Briefly, a dilution series (12.2 nM to 250 μM) of each individual amino acid standard was made containing the same concentration of the heavy standards as was in the amino acid extraction buffer. Samples were injected into a Quattro micro API LC/MS/MS (Waters) equipped with an Acquity UHPLC HSS T3 1.8 μm column (Waters) using a three-function method. The 13 min LC method with solvent A (10 mM PFHA) and solvent B (acetonitrile) at a flow rate of 0.3 mL/minute is provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. Amino acids were quantified by comparison to their standard curves using QuanLynx.

EdU staining {#s4-6}
------------

EdU (5-ethynyl-2\'-deoxyuridine) staining of root apical meristem was performed using Click-iT EdU Alexa Fluor 488 Imaging Kit (Invitrogen, C10337), following a protocol that was adapted for plant tissues ([@bib35]). Labeling was performed by incubating 10 day old Arabidopsis seedlings in 10 μM EdU in Arabidopsis growth medium (½ LS and 1% sucrose) for 30 min in a Percival chamber. All samples were then incubated with a fixation buffer (4% formaldehyde, 0.1% Triton X-100, 1 × PBS) for 30 min. All samples were washed for three times, 10 min each, with 1 × PBS after fixation. The EdU detection was conducted by 30 min incubation in dark with the Click-iT cocktail, which was prepared according to the manual of Click-iT EdU Alexa Fluor 488 Imaging Kit. Each sample was immediately washed for three times, 10 min each, with 1 × PBS before imaging.

PI staining of root tip and measurement {#s4-7}
---------------------------------------

PI (propidium iodide) staining was conducted by 3 min incubation of Arabidopsis seedlings in propidium iodide (Invitrogen, P3566) diluted to 1 μg/mL using Arabidopsis growth medium (½ LS and 1% sucrose). After staining, all samples were immediately washed for 1 min and then subjected to imaging. Confocal images of propidium iodide stained root tips were analyzed using Cell-O-Tape ([@bib26]), which is a plugin of ImageJ that automatically segments three zones in a root tip (the meristem, the transition zone and the mature zone) by comparing the lengths of adjacent cells in the same cortical layer. Adjacent cells with significant increase in cell length belong to the transition zone. Cells before and after the transition zone are categorized as cells in the meristem and the mature zone respectively. The program records the length of each cell and the cell number in each zone.

Protein preparation and immunoblotting {#s4-8}
--------------------------------------

To detect the phosphorylation status of S6K, 50 mg plant aerial tissue was used for protein extraction using 1.5 mL extraction buffer of 1 × PBS, pH 7.4, containing 250 mM sucrose, Protease Inhibitor Cocktail (Sigma-Aldrich, P9599) and PhosSTOP phosphatase inhibitor (Roche, 4906845001). Three times of centrifugation, 1 k × g for 5 min, 14 k × g for 5 min and 135 k × g for 30 min, were conducted to separate the soluble proteins. The supernatant from the last centrifugation was separated, concentrated to 200 μL using an Amicon Ultra centrifugal unit (Millipore, UFC501024), and then mixed with 40 μL 6 × Laemmli buffer. Proteins were denatured by incubation at 95°C for 10 min. Protein samples were separated on 15% SDS-PAGE with 8M urea and blotted to PVDF membranes (Bio-Rad, 1620177). Blots were blocked with 5% milk for 1 hr at room temperature. Blots were incubated with primary antibodies of either anti-S6K (Agrisera, AS12 1855) or anti-S6K-phosphorylated (Abcam, ab207399) overnight at 4°C and subsequently with secondary HRP conjugated goat anti-rabbit antibody (Sigma-Aldrich, A0545) for 1 hr at room temperature.

Extraction and measurement of anthocyanins {#s4-9}
------------------------------------------

The aerial parts of 10 day old Arabidopsis seedlings were collected, and then lyophilized and measured for dry weight. Total anthocyanins were extracted using 1 μL extraction buffer (50% methanol containing 3% formic acid) per 50 μg dry weight. After overnight incubation with extraction buffer at room temperature, the supernatant was collected and measured absorbance of 532 nm.

TEM and measurement of leaf thickness {#s4-10}
-------------------------------------

The electron microscopic imaging of the endomembrane structures and chloroplasts were performed following an established protocol ([@bib33]). In brief, 1 mm ×1 mm pieces of cotyledon samples were cut and fixed in TEM fixative buffer (2.5% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4) with vacuum infiltration. The fixed samples were stained with 1% osmium tetroxide overnight at 4°C. After series of dehydration with acetone, the samples were infiltrated and embedded in Spurr's Resin. Sections with 50 nm thickness were cut and mounted on the copper grid and 10 well slides. For TEM, the grids were post-stained in 2% uranyl-acetate for 30 min and then treated with 1% lead citrate for 15 min. JEOL 100CX TEM (JEOL USA) was used to observe the ultrastructure of cotyledon.

The thickness of cotyledons was measured as previously described ([@bib74]). Briefly, 2 mm ×1 mm samples cut from the center of the cotyledons were fixed in fixative buffer (4% paraformaldehyde and 0.5% glutaraldehyde in 1 × PBS, pH 7.4) with vacuum infiltration. The fixed samples were stained with 1% osmium tetroxide overnight at 4°C. After series of dehydration with acetone, the samples were infiltrated and embedded in Spurr's Resin. Sections with 500 nm thickness were cut and mounted on the copper grid and 10 well slides. For leaf thickness analysis, the sections were stained with 1% toluidine blue for 1 min and washed with running water. Images were taken using Axio Imager M2 (Zeiss), and measurement of leaf thickness was performed using AxioVision SE64 Rel. 4.9.1 (Zeiss) software. Three biological samples with three technical replicates were used to measure leaf thickness.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

We are excited about this work, because the authors elegantly utilized genetic and cell biological approaches to reveal how plant growth is linked to nutrition sensing. The authors' forward genetic approach has identified isopropylmalate synthase 1 (IPMS1), a critical enzyme for Leu biosynthesis, as a modulator of vacuolar morphology. The authors' in-depth characterization of this mutant revealed that the homeostasis of branched-chain amino acids impacts TOR activity and, thereby, modulates actin cytoskeleton organization. In addition, the authors provide evidence that this mechanism has an immediate influence on plant expansion.

**Decision letter after peer review:**

Thank you for submitting your article \"Homeostasis of Branched-Chain Amino Acids Is Critical for the Activity of TOR Signaling in Arabidopsis\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Jürgen Kleine-Vehn as the Reviewing Editor, and the evaluation has been overseen by Christian Hardtke as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers were largely positive about your forward genetic approach and in depth characterization of how the homeostasis of branched-chain amino acids impact on TOR-dependent subcellular processes. However, your manuscript would require substantial revision before being suitable for publication at *eLife*. Mandatory revisions should include:

1\) The reviewers did not insist on the genetic interaction data, but encourage you to include it in case the experiments are currently ongoing. On the other hand, they ask you to use the TOR inhibitors in combination with the *ipms1* mutant (e.g. detailed response curves).

2\) The reviewers request a thorough discussion of the recent literature -- especially highlighting the work of the Ringli lab (e.g. Schaufelberger et al., 2019).

3\) They, moreover, urge the author to provide a better explanation/description and quantitative assessment of their data.

4\) The effect of BCAA addition on TOR activity (e.g. phosphorylation-specific antibodies) should be investigated, which would further support the conclusions of this paper.

Please, see the more specific comments of the reviewers below, which may guide you to further improve your manuscript.

Reviewer \#1:

In a forward genetic screen Cao et al. identified *eva1* mutants, displaying defects in the regulation of actin cytoskeleton, which correlates with several defects on endomembrane organization. The authors reveal that *eva1* mutation disrupts IPMS1 and thereby impact on branched amino acid synthesis, which in turn indirectly modulates the TOR signaling. Moreover, interference with the TOR pathway phenocopies the cellular phenotypes of *eva1*.

The work is of high quality, but largely lacks quantifications and I have several concerns that I would like the authors to address.

Genetic interference with the TOR pathway in *eva1* (by crossing tor-es) would be really nice.

The authors propose that the root organ growth defects in *eva1* is due to altered TOR responses. It would be hence nice to test this hypothesis by gradually reducing TOR activity (concentration range of drugs and inducer for inducible line) in *eva1*. If causal for the root growth defects, these conditions should rescue the root length. A similar approach (using low drug concentrations) could be used to proof the causality for latrunculin B as well as wortmannin. (Please, see Supplementary data in Barberon et al., 2014 where the authors used wortmannin in a similar manner.)

The authors provide a model, assuming that TORC1 and TORC2 is differentially activated by BCAA. This conclusion is based on the fact that *raptor1b* mutants failed to suppress the BCAA-induced bundling of actin. However, the phenotype was not quantitatively addressed. In general, it would be, hence, nice to truly quantify these subcellular phenotypes (lack of quantification is apparent in Figure 1; Figure 1---figure supplements 1 and 2; Figure 4---figure supplement 4; Figure 5; Figure 5---figure supplement 1; Figure 6; Figure 6---figure supplement 1; Figure 7; Figure 7---figure supplement 1). Besides, Raptor 1a is likely redundant and hence the lack of single mutant phenotype is not conclusive.

The authors mention some defects in vacuolar fusion of *eva1* mutants and propose in their model that also the TOR pathway controls vacuolar fusions. These defects are not visible in the provided data and would need additional depiction (and quantifications). In this regard, the authors assume that wortmannin induced vacuolar fusions, which also reverses certain aspects of the *eva1* phenotype. However, it is unclear whether this relates to vacuolar fusion, because this impact could also be due to the (presumably indirect) effect of wortmannin on actin dynamics (see Supplementary data in Scheuring et al., 2016).

Reviewer \#2:

This manuscript reports on a new link in plants between the activation of the conserved and important Target of Rapamycin (TOR) kinase and the accumulation of branched-chain amino-acids (BCAA). This link has been well described in yeast and animal cells but was so far not established in plants. These findings are clearly of interest since the mechanisms linking TOR to nutrients are much less characterized in plants then in other eukaryotes.

The authors have used a forward genetic screen for defects in vacuolar morphology in Arabidopsis and have uncovered a mutation in an enzyme (IPMS1) involved in Leu biosynthesis. The authors then showed that disruption in BCAA homeostasis through *ipms1* mutations result in pleiotropic defects in AA metabolism, growth and developments of the mutant lines as well as perturbations in ER and actin networks. Finally, these defects were linked to activation of the TOR signalling pathway by pharmaceutical and genetic means.

The findings in this manuscript are novel, and the claims are most of the time well supported by the solid and convincing experimental results. This paper is very well presented and easy to read.

Nevertheless, I have a few issues which would need to be resolved by the authors.

1\) In a very recent paper, Schaufelberger et al., 2019, found that a mutation in IPMS1 suppresses the *lrx1* phenotype (aberrant root hairs) that is also suppressed by TOR. This *ipms1* allele, called *rol17*, shows reduced sensitivity to the TOR inhibitor AZD8055 suggesting higher TOR activity. I believe that this publication should be cited and discussed. For example the effect of *ipms1* mutation on root hair morphology in response to TOR is already described in this published article, although in a different genetic context. By the way, the JEB special issue in which this paper appeared also provides some more recent reviews on the TOR pathway in plants which could be added in the Introduction section.

2\) To better support their claims, I think that the authors could explore the effect of BCAA supplied to the plant growth medium on TOR activity.

3\) In Figure 7, the authors convincingly show that TOR activity is needed to observe the effects of BCAA on actin organization. I wonder how was the \"red line\" defined and positioned? Are the fluorescence profiles consistent across the images? Maybe some kind of statistical analysis would be needed here to support the authors\' conclusions.

4\) From the analysis of a raptor mutant (a specific component of the TORC1 complex) in Figure 7, the authors concluded that the impact of BCAA is not linked to TORC1 but maybe to a putative plant TORC2 complex. While the TORC2 complex has been identified and well described in yeast and animals, the existence of such a complex in plants remains elusive. Moreover, there are two Raptor genes in Arabidopsis and the single raptor1 mutants displays limited phenotypic changes, while the raptor double mutants are more severely affected (see Anderson et al., 2005). Double raptor mutants could be used here but are barely viable. I think that authors should be more cautious in their conclusions on the role of TORC1 in BCAA activation of TOR. Moreover, Son et al. and Ericksen et al. recently showed (Cell Metabolism 2019) that Leu and BCAA effect is TORC1-dependent.

Reviewer \#3:

The analysis of *eva1* as a modulator of actin and vacuole development is interesting. The connection to TOR is interesting as well. However, the authors must have overseen the publication by Schaufelberger et al., 2019, demonstrating that mutations in IPMS1 influence TOR. Thus, the novelty of an IMPS1 mutation affecting the TOR network is not new; the type of data are still new since this other publication used a completely different approach and made other analyses. It is important, however, that the authors address this paper and take it into consideration in their Discussion. Several times in the manuscript, it is difficult for a non-specialist reader to understand how the analyses were done (e.g. Figure 7) and the conclusions were drawn.

The following points should be addressed (there are neither page nor line numbers, which makes it difficult to indicate the position in the text!):

1\) The Abstract is not ideal; what does glucose have to do with BCAA (considering that at this point, the reader doesn\'t know about BCAA\'s role in TOR)

2\) The Introduction should contain information on vacuole development and introduce the experimental set-up. What are TVSs? What is the GFP-TIP line? What construct was used? Alternatively, the screen should be introduced at the beginning of the Results section. It seems that the EMS screen was not done with the GFP-TIP expressing line? This is unclear.

3\) The Introduction should also introduce the Schaufelberger et al. paper since it has direct implications on the results presented.

4\) According to the data shown, *eva1* roots have more cells in the different zones, longer zones, longer cells, and increased meristem activity. How is it possible that the roots are shorter than the wild type?

5\) In \"loss of function of IPMS1....\": homotypic vacuoles and F-actin bundling are affected and influenced by TOR, but there is no evidence that this is directly caused by the altered Leu biosynthesis. In fact, the authors show that TOR is the link between Leu biosynthesis and these observed cellular effects.

6\) Explain, how the experiment on the retention of SEC-RFP was done.

7\) I don\'t understand Figure 7. what are the graphs? The explanation in the legend doesn\'t clarify. Please re-formulate

8\) The Discussion remains rather superficial and does not really go into the details of the findings or just don\'t mention them again. For example, what do we learn from the change in chloroplast/grana structures? How come that a short root has more and longer cells and a more active meristem? TOR activity seems increased, which would produce longer roots (inhibiting TOR by AZD or Torin treatment causes shorter roots). How do the findings fit with the literature on vacuole development.? Importantly, put it in the context of the Schaufelberger et al. (JXB). There, inhibiting TOR mimics the effect of the mutation in *ipms1*, which is different from the findings described here. Also, *imps1* and inhibiting TOR by AZD suppresses a mutation in an LRR-extensin gene, encoding a type of protein that influences vacuole development (Dünser et al., 2019). Thus, there is published evidence that support the findings described in this manuscript, and this should be discussed.
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Author response

> \[...\] 1) The reviewers did not insist on the genetic interaction data, but encourage you to include it in case the experiments are currently ongoing. On the other hand, they ask you to use the TOR inhibitors in combination with the ipms1 mutant (e.g. detailed response curves).
>
> 2\) The reviewers request a thorough discussion of the recent literature -- especially highlighting the work of the Ringli lab (e.g. Schaufelberger et al., 2019).
>
> 3\) They, moreover, urge the author to provide a better explanation/description and quantitative assessment of their data.

Done. As a result the following data charts have been supplemented: Figure 1---figure supplement 1C, D; Figure 1---figure supplement 2F; Figure 3E; Figure 3---figure supplement 2D; Figure 5---figure supplement 1I; Figure 6G, I, K; Figure 6---figure supplements 2 and 3.

> 4\) The effect of BCAA addition on TOR activity (e.g. phosphorylation-specific antibodies) should be investigated, which would further support the conclusions of this paper.

Done. We investigated the effect of BCAA supplementation on TOR kinase activity by following the phosphorylation status of S6K. The revised panels H and I in Figure 6 provide an additional condition of growing wild type on medium containing 1mM BCAAs, which showed increased phosphorylation status of S6K.

> Please, see the more specific comments of the reviewers below, which may guide you to further improve your manuscript.
>
> Reviewer \#1:
>
> \[...\] The work is of high quality, but largely lacks quantifications and I have several concerns that I would like the authors to address.
>
> Genetic interference with the TOR pathway in eva1 (by crossing tor-es) would be really nice.
>
> The authors propose that the root organ growth defects in eva1 is due to altered TOR responses. It would be hence nice to test this hypothesis by gradually reducing TOR activity (concentration range of drugs and inducer for inducible line) in eva1. If causal for the root growth defects, these conditions should rescue the root length. A similar approach (using low drug concentrations) could be used to proof the causality for latrunculin B as well as wortmannin. (Please, see Supplementary data in Barberon et al., 2014 where the authors used wortmannin in a similar manner.)

We investigated the effects of increasing concentrations of AZD-8055, wortmannin and latrunculin B on primary root elongation. The supplemented experiments and quantification are presented in Figure 5---figure supplement 2 and 3. Figure 5---figure supplement 2 shows that the effect of TOR inhibitor AZD-8055 on *ipms1* primary root elongation is dose-dependent. Lower concentrations (0.1 and 0.2 μM) of AZD-8055 promote growth; however, as plausible because of TOR inhibition, higher concentrations (0.4, 0.6 and 1.0 μM) of AZD-8055 inhibit *ipms1* primary root elongation. By comparison, even a minimal concentration of AZD-8055 inhibits wild type primary root elongation.

As we explained in the manuscript, wortmannin is a PI3K/TOR dual inhibitor, and therefore it may exert multiple effects on plant growth. Barberon et al., 2014 PNAS, Supplementary Figure 3 presents a minimal but significant inhibition of wild type primary root elongation by 1, 10 and 33 μM wortmannin (n ≥ 8). Consistently, our investigation found that 33 μM wortmannin significantly inhibits primary root elongation of wild type and three *ipms1* lines (Figure 5---figure supplement 3C, n = 50 and 100). However, 1 or 10 μM wortmannin did not significantly inhibit wild type primary root elongation. Interestingly, primary root elongation of *ipms1-4* and *ipms1-5* was significantly increased by 1 μM wortmannin, which indicates pharmaceutical inhibition of TOR activity in *ipms1* promotes plant growth, consistent with the AZD-8055.

Despite primary root elongation of wild type and *ipms1* mutants being inhibited by the actin polymerization inhibitor latrunculin B (Lat B), *ipms1* mutants result more resistant to Lat B (Figure 5---figure supplement 3D-F). The previously presented Figure 4---figure supplement 4 proposed the effect of Lat B on later stages of development of the root system (e.g. formation of lateral roots) and, consistent with Figure 5---figure supplement 3D-F, showed that *ipms1* mutants are more resistant to Lat B.

> The authors provide a model, assuming that TORC1 and TORC2 is differentially activated by BCAA. This conclusion is based on the fact that raptor1b mutants failed to suppress the BCAA-induced bundling of actin. However, the phenotype was not quantitatively addressed. In general, it would be, hence, nice to truly quantify these subcellular phenotypes (lack of quantification is apparent in Figure 1; Figure 1---figure supplements 1 and 2; Figure 4---figure supplement 4; Figure 5; Figure 5---figure supplement 1; Figure 6; Figure 6---figure supplement 1; Figure 7; Figure 7---figure supplement 1). Besides, Raptor 1a is likely redundant and hence the lack of single mutant phenotype is not conclusive.

In this manuscript, we do not show evidence or propose that potential plant TORC1 and TORC2 are differentially activated. The study of potential differential activation is essentially constrained because TORC2 has not been identified. So far only a single TOR and two TOR interactors, Raptor and LST8, have been identified in plants. In yeast and mammalian models, the Raptor homolog is the defining component of TORC1 and the LST8 homolog exists in both TORC1 and TORC2. Besides, sensors and signaling components of the amino acid sensing pathway upstream of TOR are also unknown in plants.

We used a well-characterized T-DNA insertion mutant of *AtRaptor1B* (also known as *Raptor2*) because of several considerations. Deprost et al., 2005 found disruption of *AtRaptor1A (Raptor1*) has no visible effects on embryo and plant development; Anderson et al., 2005 found *raptor1a* mutant shows almost no changes in their morphology and development; Pu et al., 2017 found *raptor1a* mutant shows minimal defects in autophagy. Therefore, later studies only used *raptor1b* mutant to characterize the functions of TORC1(Salem et al., 2017; Salem et al., 2018; Wang et al., 2018). Besides, the *raptor1ab* double mutant is possibly not informative, because its growth is severely affected and barely viable after embryogenesis (Anderson et al., 2005). Moreover, it is important to consider the multiple layers of reciprocal regulation between TORC1 and TORC2 in yeast and mammalian cells (covered by reviews of Saxton and Sabatini, 2017, and Xie et al., 2018). Therefore, it may not be possible to find a situation, such as the *raptor1ab* double mutant, where TORC1 is completely disabled, while TORC2 is still not affected.

To address your point on quantification, we revised the following figures. Figure 1A and Figure 1---figure supplement 1: To provide quantitative data to describe the vacuolar phenotypes of *eva1/ipms1*, we measured the number of unfused vacuoles and the length of trans-vacuolar strands (TVSs) in cells expressing the tonoplast marker GFP-δTIP. We clarified that we defined unfused vacuoles as spherical structures that are isolated from the large central vacuole and with diameter \> 5 μm. Notably, the TVSs were rarely, if ever, observed in 10-day old cotyledon cells of wild type, but very abundant in the mutant. We underlined this marked differences in the text and legend relevant to Figure 1. Because of the obvious phenotype, we did not quantify TVSs in the later figures.

In Figure 1---figure supplement 1, we used γTIP-YFP to show the *eva1* vacuolar phenotypes are not an artefact due to the choice of GFP-δTIP marker. However, compared to GFP-δTIP, γTIP-YFP labeled numerous additional vacuolar structures. The nature of these vacuolar structures is still not well understood (Gattolin et al., 2010), and the unfused vacuoles are not clearly shown by γTIP-YFP. Therefore, we did not see the necessity to quantify the TVSs and but we provided magnified images showing the enhanced TVSs in *eva1* background for comparison to wild type.

Figure 1---figure supplement 2: We quantified the number of unfused vacuoles in each cell.

Figure 4---figure supplement 4 presents photographs showing primary root elongation on Lat B medium, which are already accompanied with quantification of primary root elongation.

Figure 5, Figure 5---figure supplement 1: We measured the number of unfused vacuoles in each cell, in wild type and in mutant, before and after inhibitor treatment. A chart was added to the figure supplement.

Figure 6 and Figure 6---figure supplement 1: We quantified the number of unfused vacuoles, and a chart was added as Figure 6G. We also quantified S6K-p/S6K ratio following an example of Dong et al., 2017, and a chart was added to the figure.

Figure 6I. We quantified EdU intensity using relative unit of fluorescence intensity, and the chart was added as Figure 6K.

Figure 7, Figure 7---figure supplement 1: We revised the figure legends to clarify the experimental setup and the interpretation that show strikingly induced actin bundling.

> The authors mention some defects in vacuolar fusion of eva1 mutants and propose in their model that also the TOR pathway controls vacuolar fusions. These defects are not visible in the provided data and would need additional depiction (and quantifications). In this regard, the authors assume that wortmannin induced vacuolar fusions, which also reverses certain aspects of the eva1 phenotype. However, it is unclear whether this relates to vacuolar fusion, because this impact could also be due to the (presumably indirect) effect of wortmannin on actin dynamics (see Supplementary data in Scheuring et al., 2016).

Our data support that unfused vacuole phenotype is due to TOR activation. First, the unfused vacuole phenotype is observed in *ipms1* mutants (Figure 1A; Figure 1---figure supplement 2D) and wild type growing with BCAA supplementation (Figure 7---figure supplement 3), which we showed are associated with up-regulated TOR signaling. Furthermore, the unfused vacuole phenotype is recovered by TOR inhibitor AZD-8055 and Torin2 (Figure 6A-F; Figure 6---figure supplement 1; Figure 7---figure supplement 3). These results have been discussed in light of a large number of recent publications in yeast and mammalian cells, which indicate that the dynamic fusion, fission and size of vacuoles and lysosomes are controlled by TOR signaling through yet unknown mechanisms. We included discussion of two representative publications (Yu et al., 2010; Michaillat et al., 2012) showing that depending on the nutrient status TORC1 regulates the size and number of yeast vacuoles and mammalian lysosomes (subsection "Plant endomembrane homeostasis is correlated with TOR activity").

Wortmannin inhibits PI3K and PI4K activity and phospholipid synthesis in plant cells (Matsuoka et al., 1995 JCB), and therefore it directly effects the membrane fusion machinery (Wickner, 2010 Annu Rev Cell Dev Biol). Wortmannin-induced vacuole fusion has been demonstrated by several studies in plant cells (Wang et al., 2009; Cui et al., 2014; Alvarez et al., 2016 JXB; Zheng et al., 2014). Importantly, Wm and LY294002 are effective inhibitors of mammalian TOR (Brunn et al., 1996) and are considered as PI3K/TOR dual inhibitors (Benjamin et al., 2011). Our work supports that caution should be taken when interpreting wortmannin's effects on vacuole and actin in the study of membrane traffic in general. Indeed, our work supports that the role of TOR as master regulator of actin organization is conserved.

> Reviewer \#2:
>
> \[...\] I have a few issues which would need to be resolved by the authors.
>
> 1\) In a very recent paper, Schaufelberger et al., 2019) found that a mutation in IPMS1 suppresses the lrx1 phenotype (aberrant root hairs) that is also suppressed by TOR. This ipms1 allele, called rol17, shows reduced sensitivity to the TOR inhibitor AZD8055 suggesting higher TOR activity. I believe that this publication should be cited and discussed. For example the effect of ipms1 mutation on root hair morphology in response to TOR is already described in this published article, although in a different genetic context. By the way, the JEB special issue in which this paper appeared also provides some more recent reviews on the TOR pathway in plants which could be added in the Introduction section.

We highlighted the work of Schaufelberger et al., 2019, in the Introduction, where we first introduced the concepts of BCAAs, IPMS and TOR (Introduction, third paragraph). Additionally, we thoroughly discussed the results in Schaufelberger et al., 2019, in the first section of Discussion (and subsection "Plant endomembrane homeostasis is correlated with TOR activity").

> 2\) To better support their claims, I think that the authors could explore the effect of BCAA supplied to the plant growth medium on TOR activity.

We investigated the effects of BCAA supplementation on TOR kinase activity by detecting the phosphorylation status of S6K. The revised Figure 6H and I provide an additional condition of growth of wild type on medium containing 1mM BCAAs, which showed increased phosphorylation status of S6K.

> 3\) In Figure 7, the authors convincingly show that TOR activity is needed to observe the effects of BCAA on actin organization. I wonder how was the \"red line\" defined and positioned? Are the fluorescence profiles consistent across the images? Maybe some kind of statistical analysis would be needed here to support the authors\' conclusions.

We are grateful for the appreciation of an evident connection between the actin reorganization phenotype and TOR activation, which highlights a role of TOR as a conserved master regulator of actin organization. To our knowledge, such a drastic reorganization has been reported in mammalian cultured cells upon TOR stimulation, but has not been reported in intact organisms. In order to clarify the experimental setup and the interpretation, we revised the description in figure legends. Higher fluorescence intensity of the actin marker suggests more bundling of actin filaments. Using ImageJ, we drew a 50 μm arrowed line to detect the fluorescence intensity of the pixels covered by such a line. In each image, the arrowed line is positioned where we detected the highest fluorescence intensity in non-saturating imaging conditions. A chart beneath the image presents plotted fluorescence intensity along the red arrowed line. Without actin bundling, fine actin filaments have fluorescence intensity about 1000 (relative units). In contrast, induced actin bundling show fluorescence intensity peaks of 3000 -- 4000 (relative units). The images were acquired with the same confocal image settings of laser, detectors and pinhole aperture.

> 4\) From the analysis of a raptor mutant (a specific component of the TORC1 complex) in Figure 7, the authors concluded that the impact of BCAA is not linked to TORC1 but maybe to a putative plant TORC2 complex. While the TORC2 complex has been identified and well described in yeast and animals, the existence of such a complex in plants remains elusive. Moreover, there are two Raptor genes in Arabidopsis and the single raptor1 mutants displays limited phenotypic changes, while the raptor double mutants are more severely affected (see Anderson et al., 2005). Double raptor mutants could be used here but are barely viable. I think that authors should be more cautious in their conclusions on the role of TORC1 in BCAA activation of TOR. Moreover, Son et al. and Ericksen et al. recently showed (Cell Metabolism 2019) that Leu and BCAA effect is TORC1-dependent.

We used a well-characterized T-DNA insertion mutant of *AtRaptor1B* (also known as

*Raptor2*) because of several considerations. Deprost et al., 2005 found disruption of *AtRaptor1A (Raptor1*) has no visible effects on embryo and plant development, and Anderson et al., 2005 found *AtRaptor1A* T-DNA lines show almost no changes in their morphology and development. However, we agree that the *raptor1ab* double mutant would not be informative because its growth is severely affected and it is barely viable after embryogenesis (Anderson et al., 2005). Moreover, it is important to consider the multiple layers of reciprocal regulation between

TORC1 and TORC2 in yeast and mammalian cells (covered by reviews of Saxton and Sabatini, 2017, and Xie et al., 2018). Therefore, it may not be possible to find a situation, such as the *raptor1ab* double mutant, where TORC1 is completely disabled, while TORC2 is still not affected.

We appreciate your suggestions about the two recent papers of Cell Metabolism. Son et al., found that a metabolite of Leu promotes Raptor acetylation and mTORC1 activation. Ericksen et al., found that loss of BCAA catabolism enhances mTORC1 activity during tumor development. These two papers provide important evidence supporting that amino acid sensing is upstream of mTORC1. However, considering the complexity of amino acid sensing mechanisms (e.g., various sensors for specific amino acids and signaling components, mostly reviewed by Kim and Guan, 2019), BCAAs may also signal to mTORC2 in a mTORC1-independent manner. In two seminal studies of mTORC2, Sarbassov et al., 2004, found Rictor and mTOR, but not Raptor, are required for PKC phosphorylation and actin organization; Jacinto et al., 2004, found nutrient repletion after starvation stimulates actin organization. Nevertheless, much less is known about the activation mechanism of mTORC2 than that of mTORC1. Therefore, we discussed this issue in the manuscript and added a question mark for TORC2 activation by BCAAs in the proposed model (Figure 8).

> Reviewer \#3:
>
> The analysis of eva1 as a modulator of actin and vacuole development is interesting. The connection to TOR is interesting as well. However, the authors must have overseen the publication by Schaufelberger et al., 2019, demonstrating that mutations in IPMS1 influence TOR. Thus, the novelty of an IMPS1 mutation affecting the TOR network is not new; the type of data are still new since this other publication used a completely different approach and made other analyses. It is important, however, that the authors address this paper and take it into consideration in their Discussion. Several times in the manuscript, it is difficult for a non-specialist reader to understand how the analyses were done (e.g. Figure 7) and the conclusions were drawn.
>
> The following points should be addressed (there are neither page nor line numbers, which makes it difficult to indicate the position in the text!):

Thank you for your suggestions on the format. We added line numbers and page numbers for the convenience of your reviewing process. The other suggestions also have been carefully addressed as the followings.

> 1\) The Abstract is not ideal; what does glucose have to do with BCAA (considering that at this point, the reader doesn\'t know about BCAA\'s role in TOR)

To make a clear introduction, we revised "a functional connection of TOR with glucose availability has been demonstrated" to "a functional connection of TOR activation with glucose availability has been demonstrated" (line 12).

> 2\) The Introduction should contain information on vacuole development and introduce the experimental set-up. What are TVSs? What is the GFP-TIP line? What construct was used? Alternatively, the screen should be introduced at the beginning of the Results section. It seems that the EMS screen was not done with the GFP-TIP expressing line? This is unclear.

We appreciate your suggestion on the necessity of introducing plant vacuoles at the beginning of the manuscript. A paragraph of the revised Introduction (from line 78) is dedicated to introduce plant vacuoles and ER. The forward genetic screen used an EMS-mutagenized GFPδTIP line to identify mutants defective in vacuole morphogenesis. To provide more information of GFP-δTIP, we introduced the full name "tonoplast intrinsic protein". Cutler et al., 2000, generated the GFP-δTIP construct and established it is a vacuolar marker. The original screen of GFP-δTIP labeled vacuolar mutants was carried out by Avila et al., 2003.

> 3\) The Introduction should also introduce the Schaufelberger et al. paper since it has direct implications on the results presented.

We introduced the work of Schaufelberger et al., 2019, in the Introduction, where we first discuss the concepts of BCAAs, IPMS and TOR (line 50). Additionally, we thoroughly discussed the results in Schaufelberger et al., 2019, in the first section of Discussion (and subsection "Plant endomembrane homeostasis is correlated with TOR activity").

> 4\) According to the data shown, eva1 roots have more cells in the different zones, longer zones, longer cells, and increased meristem activity. How is it possible that the roots are shorter than the wild type?

For *ipms1* mutants, the aberrant development of root tip (e.g., higher activity of root tip meristem and strikingly inhibited formation of root hairs) may contribute to, but certainly does not conflict with, shorter primary root. "Primary root" is the centric and main root, while root tip with three zones is only a small fraction of the primary root. We used the term "primary root length" in text and figures to avoid confusion. Additionally, we delineated the complexity of *ipms1* root tip phenotypes. Despite *ipms1* root tips having longer zones and more cells in each zone compared to wild type, *ipms1* cell length is shorter than wild type, which is shown by a new chart Figure 3--- figure supplement 2D.

> 5\) In \"loss of function of IPMS1....\": homotypic vacuoles and F-actin bundling are affected and influenced by TOR, but there is no evidence that this is directly caused by the altered Leu biosynthesis. In fact, the authors show that TOR is the link between Leu biosynthesis and these observed cellular effects.

Our results and conclusions are not centered on altered Leu biosynthesis. Using BCAA profiling of *ipms1* mutants, other BCAA biosynthetic mutants and exogenous feeding of BCAAs, we revealed a generalized causal relationship between BCAA over-accumulation, up-regulated TOR activity, and reorganization of subcellular structures.

> 6\) Explain, how the experiment on the retention of SEC-RFP was done.

As we introduced in the subsection "The organization of ER network and actin cytoskeleton is altered in *eva1*", SEC-RFP is a bulk flow marker and its secretion to apoplast indicates proper activity of bulk-flow secretion, which is an important function of secretory pathway and endomembrane system. On the other hand, retention of SEC-RFP inside cells indicates defects in secretion, such as protein sorting in the trans-Golgi network in citation 51 and 52 (Renna et al., 2013; Renna et al., 2018). In both wild type and *eva1*, SEC-RFP is secreted to apoplast and not retained inside cells (Figure 4---figure supplement 3A), posing that although in *eva1* the organization of ER and Golgi is altered, but bulk-flow traffic is not affected. This has been verified also in other mutants, such as *gom8/rhd3-7* (Stefano et al., 2012) and *g92/sec24b* (Faso et al., 2009).

> 7\) I don\'t understand Figure 7. what are the graphs? The explanation in the legend doesn\'t clarify. Please re-formulate

We clarified the experimental setup and the interpretation of the results. Higher fluorescence intensity of the actin marker indicates more bundling of actin filaments. Using ImageJ, we drew a 50 μm arrowed line to detect the pixel fluorescence intensity beneath such a line. In each image, the arrowed line is positioned where we detected the highest fluorescence intensity using non-saturating imaging settings. A chart beneath the image presents plotted fluorescence intensity along the red arrowed line. Without actin bundling, fine actin filaments have fluorescence intensity about 1000 (relative unit). In contrast, induced actin bundling show fluorescence intensity peaks of 3000 -- 4000 (relative unit). The images were acquired with the same confocal image settings of laser, detectors and pinhole aperture.

> 8\) The Discussion remains rather superficial and does not really go into the details of the findings or just don\'t mention them again. For example, what do we learn from the change in chloroplast/grana structures? How come that a short root has more and longer cells and a more active meristem? TOR activity seems increased, which would produce longer roots (inhibiting TOR by AZD or Torin treatment causes shorter roots). How do the findings fit with the literature on vacuole development.? Importantly, put it in the context of the Schaufelberger et al., 2019. There, inhibiting TOR mimics the effect of the mutation in ipms1, which is different from the findings described here. Also, imps1 and inhibiting TOR by AZD suppresses a mutation in an LRR-extensin gene, encoding a type of protein that influences vacuole development (Dünser et al., 2019). Thus, there is published evidence that support the findings described in this manuscript, and this should be discussed.

We appreciate your encouragement to discuss all *ipms1* phenotypes. To our knowledge the subcellular characterization proposed in our work is novel and establishes *ipms1* as a model to study up-regulation of TOR signaling in planta at a cell and organ level. Therefore, we provided further discussion, as recommended. Here, we briefly summarize the new points as the follows. One of the most notable *ipms1* plant growth phenotypes is the increase in leaf thickness and alteration of chloroplast ultrastructure, which is similar to a knockdown mutant of isopropylmalate isomerase (IPMI), the enzyme following IPMS for Leu biosynthesis (Imhof et al., 2014). These results support an association of BCAA accumulation with defective chloroplast development. Loss of stroma thylakoid was reported in a mutant defective in photosystem I assembly (Liu et al., 2012 Plant Cell), but the underlying mechanism is unclear.

Furthermore, our data indicate that TOR activity in *ipms1* mutants is higher than wild type. In *ipms1* mutants, an inconsistency between nutrient status and the activity of TOR metabolic signaling is detrimental to plant growth and development. A supplemented measurement of primary root length on medium with increasing concentrations of AZD-8055 provides direct evidence, because low concentrations of AZD-8055 promote *ipms1* primary root elongation (Figure 5---figure supplement 2). We also found that abrupt activation of TOR affects root development possibly through actin organization, because *ipms1* mutants show severely delayed formation root hairs (Figure 3---figure supplement 2) and defective development of overall root system, despite of a higher activity of root apical meristem.

We also discussed our findings about vacuole morphogenesis and root development in light of the reports by Schaufelberger et al., 2019, and Dünser et al., 2019, in the context of BCAA activating TOR and TOR regulating vacuole morphology (Discussion, first paragraph and subsection "Plant endomembrane homeostasis is correlated with TOR activity").
